Medical Conditions

We have the blueprint for Blue Zones. But will we use it?

GSK to purchase bronchial asthma drug developer for as much as $1.4 billion in pipeline push

Sharing COVID remedy secrets and techniques is a Trojan horse that will intestine U.S. biotech

Omega Therapeutics inventory greater than doubles on Novo Nordisk weight problems drug analysis pact

The greatest diets of 2024 have 4 issues in widespread

Why ‘Dry January’ is a foul concept

Cancer-treatment developer CG Oncology information for IPO

The monetary influence of Alzheimer’s: How retirees and caregivers can put together

Iovance inventory drops 24% after it halts cancer-drug trial

Fusion Pharma climbs as radiopharmaceutical firm flagged as potential merger goal